Rajan Sharma

Stock Analyst at Goldman Sachs

(0.39)

# 3,934

Out of 4,818 analysts

4

Total ratings

33.33%

Success rate

-15.82%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$69.55	+39.47%	1	May 30, 2024
	GSK GSK plc	Initiates: Neutral	$47	$37.50	+25.35%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$30.43	+159.61%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $69.55

Upside: +39.47%

GSK plc

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $37.50

Upside: +25.35%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $30.43

Upside: +159.61%